公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 ABBOTT DIAGNOSTICOS RAPIDOS S.A.取消

149 记录

产品持有公司班级有效性
Tira de Urina Lab Strip U11 Plus10071770590ABBOTT DIAGNOSTICOS RAPIDOS S.A.II现有
URISED ANALISADOR DE URINA10071770595ABBOTT DIAGNOSTICOS RAPIDOS S.A.II现有
FAMILIA ANALISADOR QUÍMICO DE URINA10071770596ABBOTT DIAGNOSTICOS RAPIDOS S.A.II现有
Chase Buffer10071770683ABBOTT DIAGNOSTICOS RAPIDOS S.A.I现有
Bioline HCV10071770685ABBOTT DIAGNOSTICOS RAPIDOS S.A.IV04/09/2036
Bioline Chagas Ab Rapid10071770690ABBOTT DIAGNOSTICOS RAPIDOS S.A.IV14/09/2034
BIOLINE Dengue NS1 Ag10071770694ABBOTT DIAGNOSTICOS RAPIDOS S.A.III30/03/2034
BIOLINE Influenza Ag A/B/A (H1N1)10071770698ABBOTT DIAGNOSTICOS RAPIDOS S.A.III26/07/2035
HIV 1/2 3.0 Teste Imunocromatográfico10071770701ABBOTT DIAGNOSTICOS RAPIDOS S.A.IV15/06/2034
BIOLINE Dengue IgG/IgM10071770703ABBOTT DIAGNOSTICOS RAPIDOS S.A.III25/04/2035
BIOLINE TB Ag MPT64 Rapid10071770704ABBOTT DIAGNOSTICOS RAPIDOS S.A.III27/10/2033
BIOLINE Malária Ag P.f / Pan10071770707ABBOTT DIAGNOSTICOS RAPIDOS S.A.IV21/05/2027
Determine Syphilis TP10071770720ABBOTT DIAGNOSTICOS RAPIDOS S.A.IV26/05/2033
Determine HIV-1/210071770723ABBOTT DIAGNOSTICOS RAPIDOS S.A.IV26/05/2033
BIOLINE Dengue Duo10071770730ABBOTT DIAGNOSTICOS RAPIDOS S.A.III27/10/2033
Tubos Capilares10071770731ABBOTT DIAGNOSTICOS RAPIDOS S.A.I现有
LAB STRIP U11 PLUS GL10071770746ABBOTT DIAGNOSTICOS RAPIDOS S.A.II现有
Determine TB LAM Ag10071770748ABBOTT DIAGNOSTICOS RAPIDOS S.A.III11/11/2033
BinaxNOW Streptococcus pneumoniae10071770749ABBOTT DIAGNOSTICOS RAPIDOS S.A.III16/12/2033
NycoCard HbA1c10071770750ABBOTT DIAGNOSTICOS RAPIDOS S.A.II现有
BinaxNOW G6PD10071770751ABBOTT DIAGNOSTICOS RAPIDOS S.A.II现有
NYCOCARD® LEITOR II10071770765ABBOTT DIAGNOSTICOS RAPIDOS S.A.II现有
MediSafe Solo Safety Lancet10071770770ABBOTT DIAGNOSTICOS RAPIDOS S.A.II现有
Perfil Lipídico/Glicose - Cholestech10071770786ABBOTT DIAGNOSTICOS RAPIDOS S.A.II现有
Perfil Lipídico Cholestech10071770790ABBOTT DIAGNOSTICOS RAPIDOS S.A.II现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家